Igenica raises $14 million in series C extension

Cancer company Igenica Inc. (Burlingame, Calif.) raised $14 million in an extension of a series C round co-led by existing investors Third Rock Ventures and The Column Group. Existing investors 5AM Ventures and OrbiMed Advisors also participated. The extension brings the total raised in the round to $47 million; Igenica raised $33 million in the series C round in June 2012. ...